ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2720

Crucial Role of Nuclear Factor of Activated T Cell 5 (NFAT5), an Osmo-Protective Factor, in Migration and Invasion of Rheumatoid Synoviocytes

Saseong Lee1, Seung-Ah Yoo1, Ki-Jo Kim2, Chong-Hyeon Yoon3, Wan-Uk Kim4 and Bong Ki Hong1, 1Institute of Bone and Joint Diseases, The Catholic University of Korea, Seoul, South Korea, 2St. Mary's Hospital, Seoul, South Korea, 3Division of Rheumatology, Department of Internal Medicine, College of Medicine, The Catholic University of Korea, Seoul, South Korea, 4Internal Medicine, Seoul St. Mary’s Hospital, The Catholic University of Korea, Seoul, South Korea

Meeting: 2015 ACR/ARHP Annual Meeting

Date of first publication: September 29, 2015

Keywords: Rheumatoid arthritis (RA)

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Tuesday, November 10, 2015

Title: Rheumatoid Arthritis - Human Etiology and Pathogenesis Poster III

Session Type: ACR Poster Session C

Session Time: 9:00AM-11:00AM

Background/Purpose:

Fibroblast-like synoviocytes (FLS) play an important role in the progression of rheumatoid arthritis (RA). Particularly, FLS of RA patients (RA-FLS) exhibit pro-migratory and invasive characteristic reminiscent of cancer cells, destroying cartilage and bone. However, key regulators or signaling molecules responsible for this characteristic are not fully documented. Recently, we have demonstrated that nuclear factor of activated T cell 5 (NFAT5), an osmo-protective transcription factor, is crucial to the development of experimentally-induced arthritis in mice (Kim WU, et al. Arthritis Rheum 2011). Here, we investigated if NFAT5 controls migration and invasion of RA-FLS.

Methods:

The FLS were obtained from synovial tissues of RA patients. Messenger RNA (mRNA) in RA-FLS and embryonic fibroblasts, which were deficient of NFAT5 gene, were profiled using microarray technology. NFAT5 expression in the presence of interleukin 1β (IL-1β) or transforming growth factor β (TGFβ) was analyzed by western blot analysis and real-time PCR. The expression levels of tissue factor and CCL2 were measured by flow cytometry analysis and ELISA, respectively. Wound migration assay and invasion assay using matrigel chamber were conducted in vitro.

Results:

The mRNA profiling of RA-FLS transfected with NFAT5 short interfering RNA (siRNA) and embryonic fibroblasts of NFAT5 knockout mouse revealed that NFAT5 is involved in the migration and invasion in RA-FLS. Transcriptome analysis also suggested that tissue factor and CCL2 were the key target genes of NFAT5 responsible for these processes. Consistent with these results, NFAT5 was up-regulated in RA-FLS stimulated with pro-migratory and pro-invasive cytokines, including IL-1β and TGFβ. Interestingly, tissue factor and CCL2 were independently increased by TGFβ and IL-1β, respectively, although both of which were commonly regulated by NFAT5. Moreover, knockdown of NFAT5 or tissue factor using siRNAs resulted in a marked suppression of migration and invasion of RA-FLS; particularly, TGFβ-induced RA-FLS invasion and lamellipodia formation were blocked by knockdown of NFAT5 or tissue factor transcripts. SB203580, a p38 inhibitor, down-regulated TGFβ-induced NFAT5 expression, suggesting that p38 is an up-stream regulator of NFAT5 under high TGFβ conditions.

Conclusion:

The present study demonstrates first that NFAT5 is a critical regulator responsible for the migration and invasion of RA-FLS. These data also provide the evidence for a novel role of the TGFβ-NFAT5-tissue factor axis in RA-FLS invasiveness, which could be a potential target for anti-FLS therapy retarding cartilage and bone destruction.


Disclosure: S. Lee, None; S. A. Yoo, None; K. J. Kim, None; C. H. Yoon, None; W. U. Kim, Korea Healthcare Technology R&D Project, National Research Foundation of Korea (NRF) funded by the Ministry of Education, 2; B. K. Hong, None.

To cite this abstract in AMA style:

Lee S, Yoo SA, Kim KJ, Yoon CH, Kim WU, Hong BK. Crucial Role of Nuclear Factor of Activated T Cell 5 (NFAT5), an Osmo-Protective Factor, in Migration and Invasion of Rheumatoid Synoviocytes [abstract]. Arthritis Rheumatol. 2015; 67 (suppl 10). https://acrabstracts.org/abstract/crucial-role-of-nuclear-factor-of-activated-t-cell-5-nfat5-an-osmo-protective-factor-in-migration-and-invasion-of-rheumatoid-synoviocytes/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2015 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/crucial-role-of-nuclear-factor-of-activated-t-cell-5-nfat5-an-osmo-protective-factor-in-migration-and-invasion-of-rheumatoid-synoviocytes/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology